 |
Indication & Dosage |
| |
| |
| Oral |
| ANOVULATORY INFERTILITY |
| Adult:
50 mg daily for 5 days starting on the 5th day of menstrual cycle or at any time if there is amenorrhoea. If ovulation does not occur, a 2nd course of 100 mg for 5 days may be used commencing as early as 30 days after the previous therapy. Further treatment may not be recommended if pregnancy has not occurred after a total of 6 treatment cycles. |
|
| |
|
| Administration |
May be taken with or without food. |
| |
|
| Precautions |
Polycystic ovaries, evaluate presence of ovarian cyst before each cycle treatment. Uterine fibroids; visual disturbances may develop which will impair ability to drive or operate machinery. |
| |
|
Potentially Life-threatening
Adverse Drug Reactions |
ANOVULATORY INFERTILITY
|
| |
|
| Adverse Drug Reactions |
Ovarian enlargement; abdominal pain and bloating; blurred vision; hot flushes; breast discomfort; depression; multiple or ectopic pregnancies; weight gain, nausea, vomiting; endometriosis; headache, convulsions, dizziness, fatigue, vertigo, insomnia; rash. |
| |
|
|
|
